# SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

> **NCT07297030** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 37 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **RADIATION:** SIB-SCRT
- **DRUG:** CAPOX
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT07297030
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-20
- **Primary completion:** 2026-05-31
- **Final completion:** 2029-05-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07297030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07297030, "SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07297030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*